1-4 of 4
Seiichiro Yoshizawa
Close
Sort by
Journal Articles

Clonal Evolution of Therapy-Related Myeloid Neoplasm Analyzed Sequentially By Targeted Deep Sequencing Using Bone Marrow Cells

Katagiri Seiichiro, MD PhD, Kenko Azuma, PhD, Yuu Saitoh, MD, Seiichiro Yoshizawa, MD PhD, Daigo Akahane, MD PhD, Hiroaki Fujimoto, MD, Yoshikazu Ito, MD PhD, Tomohiro Umezu, PhD, Junko.H Ohyashiki, MD PhD, Kazuma Ohyashiki, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5525.
https://doi.org/10.1182/blood-2018-99-113317
Published: 2018
Journal Articles

Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1

Tomohiro Umezu, Hiroko Tadokoro, Kenko Azuma, Seiichiro Yoshizawa, Kazuma Ohyashiki, Junko H. Ohyashiki
Journal: Blood
Blood (2014) 124 (25): 3748–3757.
https://doi.org/10.1182/blood-2014-05-576116
Published: 2014
Includes: Supplemental data
Journal Articles

BCL2L11 ( BIM ) Deletion Polymorphism Is Associated with Molecular Relapse after ABL Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myeloid Leukemia with Complete Molecular Response

Seiichiro Katagiri, MD PhD, Tetsuzo Tauchi, MD PhD, Yuu Saito, MD, Tamiko Sugro, MD, Michiyo Asano, MD, Seiichiro Yoshizawa, MD PhD, Juri Sakuta, MD PhD, Daigo Akahane, MD PhD, Yuko Tanaka, MD PhD, Nahoko Furuya, MD PhD, Keiko Ando, MD PhD, Hiroaki Fujimoto, MD, Seiichi Okabe, MD PhD, Moritaka Gotoh, MD PhD, Yoshikazu Ito, MD PhD, Tomohiro Umezu, PhD, Junko H Ohyashiki, MD PhD, Kazuma Ohyashiki, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1797.
https://doi.org/10.1182/blood.V124.21.1797.1797
Published: 2014
Journal Articles

Lower Plasma Mir-92a Levels Predict Shorter Progression-Free Survival In Newly Diagnosed Symptomatic Multiple Myeloma Patients

Seiichiro Yoshizawa, MD, PhD, Tomohiro Umezu, PhD, Junko H Ohyashiki, MD, PhD, Shinsuke Iida, MD, PhD, Kazuma Ohyashiki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1879.
https://doi.org/10.1182/blood.V122.21.1879.1879
Published: 2013